Mankind Pharma Q1 Profit Falls, Revenue Jumps

  Published 11 months ago

Mankind Pharma's Q1FY26 net profit fell 18.1% YoY, while revenue surged 24.5% with strong export and segment growth.

  • EBITDA rose 26% YoY to ₹847.6 crore; margin improved slightly to 23.7% on better operational efficiency.
  • Export revenue jumped 81.1% YoY to ₹469 crore, driven by BSV consolidation and base business expansion.
  • Consumer healthcare grew 15% YoY; e-commerce share rose to 11% with strong brand performance across key products.
You might like these

Hathway Q1 PBT Surges 59%

Gold Eases Amidst Trade Deal Hopes

India's Mineral Production Grows in FY 2025-26

Jane Street Faces SEBI Crackdown, Nuvama Impacted

Vishnu Chemicals Q1 Net Rises 6%

JSW Paints Acquires Akzo Nobel India for $1.64B

Tata Motors' Iveco Deal Spurs Investor Worry

News that matters the most ⚡